2-mercaptoethylguanidine has been researched along with Glioma in 1 studies
2-mercaptoethylguanidine: proposed as a radiation protective agent; minor descriptor (75-83); on-line & Index Medicus search GUANIDINES (75-83); RN given refers to parent cpd
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-grade gliomas are one of the most aggressive human tumors with <1% of patients surviving 5 years after surgery." | 1.34 | Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors. ( Badn, W; Darabi, A; Salford, LG; Siesjö, P; Smith, KE; Visse, E, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badn, W | 1 |
| Visse, E | 1 |
| Darabi, A | 1 |
| Smith, KE | 1 |
| Salford, LG | 1 |
| Siesjö, P | 1 |
1 other study available for 2-mercaptoethylguanidine and Glioma
| Article | Year |
|---|---|
Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Enzyme In | 2007 |